SLC5A2 and type 2 diabetes mellitus: Data from the literature also suggest that SGLT2 inhibitors may reduce liver stiffness (indexed by elastometry) [13] contrasting the increased stiffness observed in T2DM [14], which parallels the decreased elasticity of arteries, particularly when albuminuria is present [15].